Europe Pharmaceutical Drug Delivery Market Growth Opportunities and Forecast by 2027
Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027Europe Pharmaceutical Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Regional Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
- Report Date : Jun 2020
- Report Code : TIPRE00011598
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 145
The Europe pharmaceutical drug delivery market is anticipated to reach US$ 562,102.6 Mn by 2027 from US$ 352,775.1 Mn in 2019; the market is projected to grow at a CAGR of 6.2% during 2020–2027.
The growth of the pharmaceutical drug delivery market is primarily attributed to the increase in the number of naturally occurring outbreaks. However, the rising cases of needlestick injuries and infections hamper the growth of the market. Further, strategic activities by manufacturers are expected to have a positive impact on the growth of the Europe pharmaceutical drug delivery market in the coming years.
Disease outbreaks are generally caused by an infection transmitted through animal-to-person or person-to-person contact, or from the environment or other media. Through its report in 2017, the World Health Organization warned that infectious diseases are emerging at a rate that has not been seen before. Since the 1970s, ~40 contagious diseases have been discovered, including SARS, MERS, Ebola, chikungunya, avian flu, swine flu, and zika; the most recent example of such outbreaks is COVID-19.
Yellow fever, dengue fever, Rift valley fever, and Zika virus infections have been among the commonly known infectious diseases occurring in France. For instance, in August 2018, the French National Reference Centre for Arboviruses (Institut Pasteur de la Guyane) reported an autochthonous (locally acquired) laboratory-confirmed case of yellow fever in an unvaccinated 47-year-old Swiss man in French Guiana. Also, Spain was one of the earliest countries where the epidemic was identified, but historians believe this was likely a result of wartime censorship. Currently, an outrageous global pandemic caused by the Novel Coronavirus, COVID-19, has taken over Spain. On 25th March 2020, Spain’s toll on this infection took over the number reported in China. The rapid surge in the number has brought the Spanish medical system to almost a brink of collapse with a chronic lack of medical supplies intended for testing treatment, and protection. Thus, the growing prevalence of infectious diseases is likely to boost the demand for pharmaceutical drug delivery systems in the region in the coming years.
In 2019, the Germany accounted for the largest share of the Europe pharmaceutical drug delivery market, and it is also expected to register the fastest CAGR during the forecast period. The growing number of the upcoming market players and increasing export of healthcare products and services, and ongoing technological advancements are the key factors supporting the largest share of this country in the regional market.
Germany Pharmaceutical Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE PHARMACEUTICAL DRUG DELIVERY
– MARKET SEGMENTATION
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Geography
Europe
- UK
- Germany
- France
- Italy
- Spain
Company Profiles
- Bayer AG
- GlaxoSmithKline plc,
- MERCK KGaA
- Pfizer Inc.
- Novartis AG
Europe Pharmaceutical Drug Delivery Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 352,775.1 Million |
| Market Size by 2027 | US$ 562,102.6 Million |
| Global CAGR (2020 - 2027) | 6.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
The List of Companies - Europe Pharmaceutical Drug Delivery Market
- Bayer AG
- GlaxoSmithKline plc,
- MERCK KGaA
- Pfizer Inc.
- Novartis AG
Get Free Sample For